Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6709 USD | -5.28% | -9.35% | -52.08% |
06-11 | Nestle's Health Unit to Take Full Control of Microbiota-Based Therapeutic | CI |
06-07 | Canaccord Genuity Adjusts Price Target on Seres Therapeutics to $10 From $15, Maintains Buy Rating | MT |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- MarketScreener Editorial Features